Heidi adds agents for clinical administration

Heidi II extends a documentation product into administrative work. Clinician review and regional availability remain central to evaluating the release.

Heidi, an Australian clinical software company, announced Heidi II on September 28, adding agents that carry out administrative work around patient visits and return results for clinician review.

The company is expanding what its software does after a consultation. Instead of only producing notes or identifying follow-up work, it offers to perform tasks. Clinicians need to judge the resulting work before relying on it.

Why it matters: Preparing a document and acting on it require different acceptance criteria. A useful administrative assistant must preserve the intended patient, destination and request throughout a workflow, not merely produce convincing prose at the end.

The launch announcement identifies agents, memory and access to peer-reviewed research as additions. It says a clinician can describe a task in ordinary language and receive the result without directing every intermediate step. These are announced capabilities, not independent measurements of accuracy or time saved.

That distinction matters for procurement. A demonstration can establish that a route through an application is possible. It cannot establish how often that route succeeds when information is missing, records conflict or a person changes the instruction midway through the task.

Consider an illustrative referral workflow. A useful evaluation would check whether the draft concerns the correct person, preserves the clinician’s stated reason and reaches the intended review queue. Reviewers should also inspect what the system did when an essential field was absent. Filling that gap with a plausible guess would be a failure, even if the form looked complete.

Memory deserves its own acceptance test. An evaluator could supply a preference, change it later and inspect which version the assistant uses. The same test should distinguish reusable preferences from facts tied to a particular encounter. This is a proposed evaluation, not a finding that Heidi mixes those categories.

The company’s rollout notice also limits the geographic scope. It describes an English-language rollout, further languages ahead and no availability in the European Union or United Kingdom. A global announcement therefore should not be read as an offer that every practice can immediately use.

Review must cover actions as well as documents

The most important design question is where the clinician’s decision occurs. Returning an output for review is useful only if the reviewer can understand what happened before that output appeared. A polished final note is insufficient evidence about which records were consulted or which systems were changed.

For a pilot, a practice could start with a narrowly defined administrative task and record the full sequence of actions. It could compare the final output with the original instruction and source records, then separately assess the time needed to review and correct it. Those measurements would be more informative than the number of tasks generated.

The evaluation should include cases in which stopping is correct. If an instruction refers ambiguously to a patient or recipient, asking for clarification may be the best outcome. A metric that counts every pause as a failure could encourage the wrong procurement decision.

There is also a difference between retrieving research and deciding that research applies. A proposed review should check publication identity and whether the cited passage supports the generated statement. Clinical applicability remains a separate professional judgment; access to a paper alone does not answer it.

Heidi’s emphasis on supervision is therefore a meaningful part of the product description, but not proof that supervision will be easy. A clinician needs enough information to review efficiently, including visible uncertainty and a way to correct the task before consequential actions are taken.

The next evidence to watch is deployment-specific: which tasks are enabled, where approval is required, what happens after a failed action and how much review work remains. Those observations will determine whether the new administrative capability returns usable time to clinicians.

Verification

Glossary candidates: agent — software using tools to perform a task; review queue — work awaiting a person’s decision; persistent memory — information retained for later interactions.

Cold-reader sentence: Heidi announced agents for clinical administration, with clinician review and regional restrictions that limit how the new capabilities can be adopted.